|
Volumn 21, Issue 9, 2001, Pages 663-666
|
CEA comprehensive evaluation for Western and traditional Chinese hypotensive drugs
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE;
ANTIHYPERTENSIVE AGENT;
BENAZEPRIL;
BENZAZEPINE DERIVATIVE;
HERBACEOUS AGENT;
INDAPAMIDE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
ECONOMICS;
FEMALE;
HUMAN;
HYPERTENSION;
MALE;
MIDDLE AGED;
PHYTOTHERAPY;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
AGED;
AGED, 80 AND OVER;
AMLODIPINE;
ANTIHYPERTENSIVE AGENTS;
BENZAZEPINES;
COST-BENEFIT ANALYSIS;
DRUGS, CHINESE HERBAL;
FEMALE;
HUMANS;
HYPERTENSION;
INDAPAMIDE;
MALE;
MIDDLE AGED;
PHYTOTHERAPY;
QUALITY OF LIFE;
|
EID: 0038814065
PISSN: 10035370
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|